Evidence map›Paper›PMID 37300590›Full record

ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2023

Clinical evaluation of a resurfacing device implant for femoral osteochondral defects greater than 1 cm

Pierre-Alban Bouché, Valerian Fiodière, Elliott Kierszbaum, François-Paul Ehkirch

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Pediatric osteochondral fractures: clinical insights associate early diagnosis to early rehabilitation via arthroscopy.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Pierre-Alban BouchéOrthopaedic Department, Hôpital Lariboisière, 2 Rue Ambroise Paré, 75010, Paris, France. pierrealban309@gmail.com.ORCID http://orcid.org/0000-0002-4117-4651
Valerian FiodièreOrthopaedic Department, Hôpital Lariboisière, 2 Rue Ambroise Paré, 75010, Paris, France.
Elliott KierszbaumOrthopaedic Department, Clinic du Landy Ramsay, 23 Rue du Landy, 93400, Saint-Ouen-sur-Seine, France.
François-Paul EhkirchOrthopaedic Department, Clinique Maussins-Nollet, 67 Rue de Romainville, 75019, Paris, France.
Hôpital Lariboisière · FRClinique du Sport · FRGénérale de Santé · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOsteochondral defects have a limited capacity to heal and can evolve to an early osteoarthritis. A surgical possibility is the replacement of the affected cartilaginous area with a resurfacing device BioPoly™ RS Partial Resurfacing Knee Implant. The aim of this study was to report the clinical and survival outcomes of the BioPoly™ after a minimum follow-up of 4 years.

methodsThis study included all patients who had a BioPoly™ for femoral osteochondral defects greater than 1 cm

resultsEighteen patients with 44.4% (8/18) of women were included with a mean age of 46.6 years (11.4), a mean body mass index (BMI) of 21.5 (kg/m

conclusionsBioPoly™ is a real alternative for femoral osteochondral defects greater than 1 cm LEVEL OF EVIDENCE: Therapeutic level III. Prospective cohort study.

Indexed as

Cartilage, ArticularCartilage DiseasesFemaleFollow-Up StudiesHumansKnee JointMiddle AgedProspective StudiesTreatment OutcomeKnee injuryOsteochondral defectProsthetic buttonSport medicine

Identifiers

PMID37300590
OpenAlexW4380152507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.